AR033753A1 - Derivados de imidazo[1,5-a]pirimido[5,4-d]benzazepina - Google Patents

Derivados de imidazo[1,5-a]pirimido[5,4-d]benzazepina

Info

Publication number
AR033753A1
AR033753A1 ARP020101805A ARP020101805A AR033753A1 AR 033753 A1 AR033753 A1 AR 033753A1 AR P020101805 A ARP020101805 A AR P020101805A AR P020101805 A ARP020101805 A AR P020101805A AR 033753 A1 AR033753 A1 AR 033753A1
Authority
AR
Argentina
Prior art keywords
lower alkyl
cycloalkyl
substituted
benzazepina
pyrimid
Prior art date
Application number
ARP020101805A
Other languages
English (en)
Spanish (es)
Inventor
Raffaello Masciadri
Ab Astrazeneca
Juergen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR033753A1 publication Critical patent/AR033753A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ARP020101805A 2001-05-18 2002-05-16 Derivados de imidazo[1,5-a]pirimido[5,4-d]benzazepina AR033753A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01112222 2001-05-18

Publications (1)

Publication Number Publication Date
AR033753A1 true AR033753A1 (es) 2004-01-07

Family

ID=8177471

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020101805A AR033753A1 (es) 2001-05-18 2002-05-16 Derivados de imidazo[1,5-a]pirimido[5,4-d]benzazepina

Country Status (37)

Country Link
US (1) US6686352B2 (https=)
EP (1) EP1399448B1 (https=)
JP (1) JP4068466B2 (https=)
KR (1) KR100533406B1 (https=)
CN (1) CN1230436C (https=)
AR (1) AR033753A1 (https=)
AT (1) ATE283857T1 (https=)
AU (1) AU2002338898B2 (https=)
BG (1) BG108369A (https=)
BR (1) BR0209859A (https=)
CA (1) CA2446903C (https=)
CZ (1) CZ20033355A3 (https=)
DE (1) DE60202147T2 (https=)
DK (1) DK1399448T3 (https=)
EC (1) ECSP034851A (https=)
ES (1) ES2232778T3 (https=)
GT (1) GT200200087A (https=)
HR (1) HRP20030890A2 (https=)
HU (1) HUP0400743A3 (https=)
IL (2) IL158572A0 (https=)
JO (1) JO2297B1 (https=)
MA (1) MA27024A1 (https=)
MX (1) MXPA03010529A (https=)
MY (1) MY127570A (https=)
NO (1) NO20035104L (https=)
NZ (1) NZ529097A (https=)
PA (1) PA8545201A1 (https=)
PE (1) PE20030041A1 (https=)
PL (1) PL366846A1 (https=)
PT (1) PT1399448E (https=)
RU (1) RU2287531C2 (https=)
SI (1) SI1399448T1 (https=)
SK (1) SK15252003A3 (https=)
TW (1) TWI251489B (https=)
WO (1) WO2002094834A1 (https=)
YU (1) YU90003A (https=)
ZA (1) ZA200308544B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2540987T3 (es) 2004-05-14 2015-07-15 Millennium Pharmaceuticals, Inc. Métodos para preparar inhibidores de la aurora cinasa
AU2005294575B2 (en) * 2004-10-04 2011-11-24 Millennium Pharmaceuticals, Inc. Lactam compounds useful as protein kinase inhibitors
ES2399439T3 (es) * 2004-10-20 2013-04-01 F. Hoffmann-La Roche Ag Derivados de imidazo-benzodiazepina
AU2005299031B2 (en) * 2004-10-20 2011-11-10 F. Hoffmann-La Roche Ag Halogen substituted benzodiazepine derivatives
KR101009860B1 (ko) * 2005-10-11 2011-01-19 에프. 호프만-라 로슈 아게 이미다조 벤조다이아제핀 유도체
PE20080145A1 (es) * 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv Tetrahidro-pirimidoazepinas como moduladores de trpv1
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
WO2009078999A1 (en) 2007-12-17 2009-06-25 Janssen Pharmaceutica N.V. Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1
CN101735211B (zh) * 2008-11-04 2012-11-14 复旦大学 2,3-二氢[1,5]苯并噻氮杂*类化合物或其盐在制备GSK-3β抑制剂中的用途
US7998952B2 (en) 2008-12-05 2011-08-16 Millennium Pharmaceuticals, Inc. Thiolactams and uses thereof
RU2535032C2 (ru) 2008-12-22 2014-12-10 Милленниум Фармасьютикалз, Инк. Сочетание ингибиторов аврора киназы и анти-cd 20 антител
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
CA2788774A1 (en) 2010-02-19 2011-08-25 Millennium Pharmaceuticals, Inc. Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoate
CN101891706B (zh) * 2010-04-09 2013-05-29 复旦大学 3,4-二氢苯并[f][1,4]噻氮杂*类化合物或其盐及其药物用途
CN102424670A (zh) * 2011-10-31 2012-04-25 江苏阿尔法药业有限公司 一种合成3-(3-氯丙基)-1,3,4,5-四氢-7,8-二甲氧基-2h-3-苯并氮杂卓-2-酮的方法
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
WO2014153509A1 (en) 2013-03-22 2014-09-25 Millennium Pharmaceuticals, Inc. Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase
EP3083569B1 (en) 2013-12-20 2022-01-26 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
JP6987384B2 (ja) 2015-06-19 2021-12-22 エージンバイオ, インコーポレイテッド ベンゾジアゼピン誘導体、組成物、および認知障害を処置するための方法
JP2018524292A (ja) 2015-07-21 2018-08-30 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. オーロラキナーゼインヒビターと化学療法剤の投与
US20180170941A1 (en) 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US11414425B2 (en) 2018-06-19 2022-08-16 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CN110452172B (zh) * 2019-08-21 2021-03-26 爱斯特(成都)生物制药股份有限公司 一种苯并己内酰胺的合成方法
CN112159411A (zh) * 2020-10-15 2021-01-01 南京工业大学 一种三氟甲基取代嘧啶并[1,3]二氮杂*化合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2607503B1 (fr) * 1986-12-02 1989-02-24 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
TW201311B (https=) 1991-06-17 1993-03-01 Hoffmann La Roche
RU2119496C1 (ru) * 1992-04-14 1998-09-27 Научно-исследовательский институт фармакологии Российской академии медицинских наук Производные n-ацилпролилдипептидов
FR2728902B1 (fr) * 1994-12-29 1997-01-31 Synthelabo Derives d'acide 8-oxo-5,8-dihydro-6h-dibenzo(a,g)quinolizine-13-propanoique, leur preparation et leur application en therapeutique
WO1999043682A1 (en) * 1998-02-26 1999-09-02 Neurogen Corporation 2-(het-)aryl-4-(cyclic amino substituted) heteroaryl fused pyridine derivatives, their preparation and their use as (ant-)agonists for gaba (a) brain receptors
US6177569B1 (en) * 1998-08-25 2001-01-23 Neurogen Corporation Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
FR2783828B1 (fr) 1998-09-29 2000-11-10 Synthelabo Derives d'acide 5,6-dihydro-4h-imidazo[1,2-a][1] benzazepine -1-acetique, leur preparation et leur application en therapeutique
CN1390217A (zh) 1999-11-12 2003-01-08 神经原公司 二环和三环杂芳族化合物
TWI239333B (en) 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators

Also Published As

Publication number Publication date
KR100533406B1 (ko) 2005-12-02
PE20030041A1 (es) 2003-02-07
WO2002094834A1 (en) 2002-11-28
ZA200308544B (en) 2005-01-31
EP1399448A1 (en) 2004-03-24
YU90003A (sh) 2006-08-17
HRP20030890A2 (en) 2005-08-31
IL158572A (en) 2010-02-17
AU2002338898B8 (en) 2002-12-03
NO20035104D0 (no) 2003-11-17
SK15252003A3 (sk) 2004-08-03
JO2297B1 (en) 2005-09-12
US20030055042A1 (en) 2003-03-20
IL158572A0 (en) 2004-05-12
DE60202147D1 (de) 2005-01-05
MY127570A (en) 2006-12-29
JP2004531563A (ja) 2004-10-14
AU2002338898B2 (en) 2007-03-15
ECSP034851A (es) 2003-12-24
SI1399448T1 (en) 2005-02-28
HUP0400743A3 (en) 2007-09-28
CA2446903A1 (en) 2002-11-28
BG108369A (bg) 2005-01-31
PA8545201A1 (es) 2003-02-28
CN1230436C (zh) 2005-12-07
US6686352B2 (en) 2004-02-03
MA27024A1 (fr) 2004-12-20
PT1399448E (pt) 2005-03-31
MXPA03010529A (es) 2004-03-02
NZ529097A (en) 2005-04-29
TWI251489B (en) 2006-03-21
HUP0400743A2 (hu) 2004-07-28
CN1509289A (zh) 2004-06-30
RU2287531C2 (ru) 2006-11-20
GT200200087A (es) 2003-06-19
ES2232778T3 (es) 2005-06-01
DK1399448T3 (da) 2005-04-11
JP4068466B2 (ja) 2008-03-26
DE60202147T2 (de) 2005-12-01
CA2446903C (en) 2008-12-30
EP1399448B1 (en) 2004-12-01
NO20035104L (no) 2003-11-17
KR20040002975A (ko) 2004-01-07
RU2003136078A (ru) 2005-05-27
BR0209859A (pt) 2004-06-15
ATE283857T1 (de) 2004-12-15
CZ20033355A3 (en) 2004-07-14
HK1066544A1 (en) 2005-03-24
PL366846A1 (en) 2005-02-07

Similar Documents

Publication Publication Date Title
AR033753A1 (es) Derivados de imidazo[1,5-a]pirimido[5,4-d]benzazepina
PE20030129A1 (es) Imidazotriazinas
CR6165A (es) Procedimientos e intermedios para preparar compuestos anticancerosos
PE10897A1 (es) Compuestos benzo fusionados
PE20121352A1 (es) Derivados de heteroarilo que contienen n como inhibidores de cinasa jak3
PE20040832A1 (es) Derivados de indolil pirazinona
ES2094843T3 (es) Bencisotiazol- y bencisoxazol-3-carboxamidas, un procedimiento para su preparacion y su empleo como medicamentos antipsicoticos.
AR017236A1 (es) Compuestos biciclo [2.2.1] heptanos, composiciones farmaceuticas, procedimientos para tratar
NO20072288L (no) Sulfonamid pert-substituerte bicykler for okklusly arteriesykdom
UY26872A1 (es) Derivados de la 4- fenil piridina
PE20051039A1 (es) [1,8] naftiridin-2-onas y compuestos relacionados
PE20040164A1 (es) Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas
ATE380818T1 (de) Piperazine-substituierte aryl-benzodiazepinen und ihre verwendung als dopaminrezeptor-antagonisten zur behandlung von psychose
PE20030735A1 (es) Derivados de benzotiazol
AR043168A1 (es) Compuestos heterociclicos derivados de oxadiazol, oxazol e isoxazol
RU2006105777A (ru) Индол-6-ильные сульфонамидные производные, их получение и их применение в качестве модуляторов 5-нт-6
AR042002A1 (es) Benzoxazinonas sustituidas, proceso de obtencion y usos para tratamiento de enfermedades del sistema nervioso central.
PE20061156A1 (es) Derivados de benzamida como agentes inhibidores del transportador de glicina
AR028475A1 (es) Derivados de azaindol y uso de los mismos para la manufactura de un medicamento para el tratamiento de la depresion.
AR031197A1 (es) Procedimiento para la preparacion de derivados de 1,2,3,4,8,9,10,10a-octahidro-7bh-ciclopenta(b) diazepino(6,7,1-hi)indol
AR041481A1 (es) Derivados de acido arilpropionico-oxazol y su uso como agonistas de ppar
AR041376A1 (es) Piperazinas sustituidas por heterociclos para el tratamiento de la esquizofrenia
AR041898A1 (es) Derivados de 4(fenil-piperazinil-metil) benzamida y sus usos para el tratamiento del dolor y desordenes gastrointestinales
AR036108A1 (es) Derivados de oxadiazol, respectivamente de tiadiazol-pirrolidina, uso de dichos derivados en la preparacion de composiciones para modular, bloquear o antagonizar la actividad de oxitocina con sus receptores y/o el tratamiento y/o prevencion de enfermedades mediadas por la oxitocina , inclusive en la
AR036735A1 (es) Derivados de 5-metoxi-8-aril-[1,2,4]triazolo[1,5-a]piridina

Legal Events

Date Code Title Description
FA Abandonment or withdrawal